(12) Patent Application Publication (10) Pub
Total Page:16
File Type:pdf, Size:1020Kb
US 2003O228616A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/022861.6 A1 Arezi et al. (43) Pub. Date: Dec. 11, 2003 (54) DNA POLYMERASE MUTANTS WITH part of application No. 09/896,923, filed on Jun. 29, REVERSE TRANSCRIPTASE ACTIVITY 2001, which is a continuation-in-part of application No. 09/698,341, filed on Oct. 27, 2000. (75) Inventors: Bahram Arezi, Carlsbad, CA (US); Holly Hogrefe, San Diego, CA (US); (60) Provisional application No. 60/162,600, filed on Oct. Joseph A. Sorge, Wilson, WY (US); 29, 1999. Connie Jo Hansen, San Diego, CA (US) (30) Foreign Application Priority Data Correspondence Address: Oct. 27, 2000 (WO)........................... PCT/USOO/29706 PALMER & DODGE, LLP KATHLEEN M. WILLIAMS / STR Publication Classification 111 HUNTINGTONAVENUE BOSTON, MA 02199 (US) (51) Int. Cl." ............................ C12O 1/68; CO7H 21/04; C12P 19/34; C12N 9/22; C12N 1/20; (73) Assignee: Stratagene C12N 15/74 (52) U.S. Cl. ............................. 435/6; 435/69.1; 435/199; (21) Appl. No.: 10/435,766 435/252.3; 435/320.1; 435/912; 536/23.2 (22) Filed: May 12, 2003 (57) ABSTRACT Related U.S. Application Data The present invention relates to compositions and kits comprising a mutant DNA polymerase with increased (63) Continuation-in-part of application No. 10/223,650, reverse transcriptase activity. The invention also relates to filed on Aug. 19, 2002, which is a continuation-in methods for using the Subject compositions and kits. Patent Application Publication Dec. 11, 2003. Sheet 1 of 26 US 2003/0228616 A1 Figure 1. Oligonucleotide primers for Quikchange mutagenesis and GAPDH target amplification F-Pfu408F 5’-CTAgATTTTAgAgCCTTCTATCCCTCgATT-3 R-Pf408F 5'-AATCgAgggATAgAAggCTCTAAAATCTAg-3 F-Pfu408Y 5'-CTAgATTTTAgAgCCTACTATCCCTCgATT-3’ R-Pful408Y 5'-AATCgAgggATAgTAggCTCTAAAATCTAg-3 F-JDFL408F 5’-CTAgACTTTCgTAgTTTCTACCCTTCAATCATAATC-3' R-JDFL408F 5'-gATTATgATTgAAgggTAgAAACTACgAAAgTCTAg-3 F-JDFL408Y 5'-CTAgACTTTCgTAgTTACTACCCTTCAATCATAATC-3' R-JDFL408Y 5’-gATTATgATTgAAggg.TAgTAACTACgAAAgTCTAg-3 F-JDFL408W 5'-CTAgACTTTCgTAgTTggTACCCTTCAATCATAATC-3' R-JDFL408W 5-gATTATgATTgAAggg.TACCAACTACgAAAgTCTAg-3 GAPDH-F 5'-CgAgCCACATCgCTCAg-3 GAPDH-R 5’-CATgTAgTTgAggTCAATgAA-3' Patent Application Publication Dec. 11, 2003 Sheet 2 of 26 US 2003/0228616 A1 Figure 2. DNA dependent DNA polymerization activity (3H-TTP inc.) of the WTs and mutants Lysate volume (pl) RNA dependent DNA polymerization activity (3H-TTP inc.) of the WTs and mutants Lysate volume (l) S og 0.8 Clis 0.7 s 0.6 EC up 0.5 9 0.4 i 5 0.3 ac9 E 0.2 2. s 0. O 5 SS -0.1 OF3 JD LF LY LW Patent Application Publication Dec. 11, 2003 Sheet 3 of 26 US 2003/0228616 A1 Figure 3 DNA dependent DNA polymerization activity (3H-TTP inc.) of the Exo plus WT and the mutants Lysate volume (ul) RNA dependent DNA polymerization activity (3H-TTP inc.) of the Exo plus WT and mutants Lysate volume (ul) Patent Application Publication Dec. 11, 2003. Sheet 4 of 26 US 2003/0228616A1 Figure 4. RNA dependent DNA polymerization activity (33P-GTP Inc.) of purified enzymes 2 of each enzyme/Rxn Patent Application Publication Dec. 11, 2003. Sheet 5 of 26 US 2003/0228616A1 Figure 5. 150 bp 2 3 4 5 1: Negative control (no StrataScript) StrataScript (2 units) exo-JDF3 (2 units) exo-JDF3 LH (2 units) exo-JDF3 LF (2 units) Patent Application Publication Dec. 11, 2003. Sheet 7 of 26 US 2003/0228616A1 Pful 571 KLPGLLELEYEGF. YKRGFFWTKKRYAWIDEEG. KVITRGLEIWRRDWSE 68 JDF 570 KPGETELEYEGE . YVRGEFWTKKKYAVIDEEG. KITRGLEIWRRDWSE 617 Tgo 570 KLPGLLELEYEGF. YKRGFFWTKKKYAVTDEED. KITTRGLEIWRROWSE 617 Tli 573 KLPGLL ELEYEGF. YLRGEFWTKKRYAVIDEEG. RITTRGLEVWRRDWSE 62O Tsp. 571 KLPGLLELEYEGF. YVRGFFWTKKKYALIDEEG. KTRGLEWRRDWSE 68 Mvo 630 ELPEGMELEFEGH. EKRGIFWTKKKYALIEDDG. HIWWKGLEWWRRDWSN 677 RB69 676 NKQHLMFMDREAIAGPPLGSKGIGGFWTGKKRYALNVWDMEGTRYAEPKLKIMGLETQKSSTPK 739 T4 672 NREHMHMDREAISCPFLGSKGVGGFWKAKKRYALNVYDMEDKRFAEPHLKIMGMETOOSSTPK 735 Eco 585 RLTSALELEYETHFCRFLMPTIRGADTGSKKRYAGLIQEG. DKQRMVFKGLETVRTDWTP 643 Patent Application Publication Dec. 11, 2003 Sheet 13 of 26 US 2003/0228616 A1 TTTTCTTGCCAGGTCTCTTGAGTTTCGCAAGGGTCTTCTCGACCAGCTCAA F S C Q V S K V S O G. S S R P A Q TGGTCTTGTCGTCATTGTTTNNNNNNNNNNNNNNNNNNNNNCCCGGGGACT W S C R H C X X X X X X X X P G T DNA : TCATACTGGCGGTAATAGACAGGGATTCCTTCCTCAAGGACTTCCCGGGAG --1 : S Y W R is k T G T P S S R T S R E DNA: GCATTGGAGTTTTTTGGTGGGGCTTTCACAGGATTTGCTCATCTTGTGGAT +1 : A. L. E. F. F. G G A F T G F A H L V D DNA: TTCTCGTTCGATTGAATCGTCCACTTGAGGGTGTAGGTCGAGACGGTGGA F S F D I C P L E G W G R D G - G DNA GCGCGTATTCCGGGAGCGGGTCTTGAGGCTCCAT"TTTTCAGTCCTCCTCCG + 1 : A R T P G A G L E A P F F S P P P DNA : GCGAAGAAGTGGAACTCAAGCCGGGTGTTAGCTTAGTTATGTTCCCAACT +1 : A K K W N S S R W L A Y V M F P T DNA: CCTCCAGCACCTCCAGGATCCCCTCAATCCCGGAACCTCGAAGCCCCTCTC P P A P P G S P Q S R N L E A P L. DNA: GTGGATCTTTCTAACTTCCTCTGCCTCCGGGTTTATCCAGACCGCCCACAT +l : W D L S N F L C L R V Y P D R P H. DNA: GCCGGCTCTCAGCGCACCCTCGAAATCCTCCGCGTAGGTGTCGCCGATGTG +1 : A G S O R T L E I L R W G V A D V DNA: GATTGCCTCGTCCGGCTCGACCCCGAAGCATCGAGCGGTTTTCTGAACATC +1 : D C L W R L D P E A S S G F L N I. DNA TCGGGCATCGGCTTATACGCCAGAACCTCGTCGGCGAAGAAGGTTCCCTCA +1 : S G T G Y A R T S S A K K V P S DNA : ATGTAGTCCATCAGGCCGAACCTCTCGAGGGGGGGCCCGGTACCCAATTCG +1 : M. le S I R P N L S R G G P W P N S DNA : CCCTATAGTGAGTCGATTACAATTCACTGGCCGTCGTTTTACAACGTCGTG +1 : P Y S E S T T H. W P S F Y N V V ACTGGGAAAACCCTGGCGTTACCCAACTTAAGTCGCTTTGCAGCACATCCC T G. K. T. L. A. L. P N L S R F A A. H. P CC Patent Application Publication Dec. 11, 2003 Sheet 14 of 26 US 2003/0228616 A1 Pfu wild type SEQ ID NO: 3 Amino acid sequence mildvdyiteegkpvirlfkkengkfkiehdirtfrpyiyallrddskieevkkitgerhgkiv rivdvek vekkf ligkpitvwklylehpqdvptirekvrehpavvdifeydipfakrylidkglipmegeeelkilafdietlyhege efgkgpiimisyadeneakvitwknidlpyvev vs seremikrflriirekdpdiivityngdsfalfpylakiraek lgikltigrdgsepkmqrigdmtavevkgrihfallyhvitrtinlptytleavyeaifgkpkekvyadeiakawe sgenlervakys medakatyeligkeflpmeiqlsrlvggplwdvsrsstgnlvewfillrkayernevapnkpsee eygrrlresy togfvkepekglwenivyldfralypsiiithnvispatlinlegcknydiapavghkfckdipgfi psllghl leerqkiktkmketcdpiekilldyrokaikllansfygyygyakarwyckecaesvtawgrkyielv wkeleekfgfkvliyidtdglyatipggeseeikkkalefvkyinsklpglleleyegfykrgffvtkkryavide egkvitrogleivrrdwsei aketcarvletilkhgdiveeavriivkevicklanyeippeklaiyeqi triplheyk aligphvavakklaakgvkikpgmvigyivlrgdgpisnraillaeeydpkkhkydaey yiendvlpavlrilegfg yrkedlryqktrovgltswlnikks SEQ ID NO: 4 Polynucleotide sequence atgattittagatgtggatta Catalactogalagaaggaaaacctgttattaggctattoaaaaaagagaacggaaaa tittaagatagagcatgatagaacttittagaccatacatttacgctcittctoaggogatgattcaaagattgaagaa gttaagaaaataacgggggaaaggcatggaaagattgttgaga attgttgatgtagagaaggttgagaaaaagttt citcggcaa.gcct attaccgtgtggaaactittatttggaacatc.cccaagatgttcc.cactattagagaaaaagtt agagaacatCcagcagttgtc.gaCat Ctt C9aatacga tatt ccatttgcaaagagatacct catcgacaaaggc ctaataccalatggagggggaagaagagctaaagattcttgcct tcgatatagaaaccctctatoacgaaggagaa gagtttggaaaagg.ccca attataatgattagttatgcagatgaaaatgaagcaaaggtgattacttggaaaaac atagatct tccatacgttgaggttgtat Caagcgagagagagatgataaagagatttctgaggattatcagggag aaggatcCtgaCattatagittacttataatggag act cattcgcatt.cccatatt tag.cgaaaagggcagaaaaa Cttgggattaaattalaccattggaa.gagatggaag.cgagccCaagatgcagagaataggcqatatgacggctgta daagtcaagggaagaatacatttcgacttgtaticatgtaataacaagga caataaatctoccaa.catacacacta gaggctgtatatgaa.gcaatttittggaaagcCaaaggagalagg tatacgc.cgacgagatagcaaaagcctgggaa agtggagaga a CCttgagagagttgcCaaatact.cgatggaagatgcaaaggcaact tatgaact.cgggaaagaa tt CCttCCaatggalaatticagctttcaagattagttggacaac Ctt tatgggatgtttcaaggtoaag cacaggg aaccttgtagagtggttct tact taggaaag.cctacgaaagaaacgaagtagctCcaaacaa.gc.caagtgaagag gagtatcaaagaaggct Cagggagagctacacagg toggatt.cgttaaagagcCagaaaaggggttgttgggaaaac at agtatacctagattittagagcc.ctatatcCCtcgattata attacccacaatgtttct cocq atactictaaat Cttgagggatgcaagaactatgatatcgct.cct Caagtaggccacaagttctgcaagga catcc cteggttittata cCaagttct cttgggacatttgttagaggaaagacaaaagattalaga caaaaatgaaggaalactCaagatcctata gaaaaaatact cottgactatagacaaaaag.cgataaaactct tag caaattctttctacggatattatggctat gcaaaag Caagatgg tactgtaaggag tetgctgaga.gcgttact.gc.ctggggaagaaagta Catcgagttagta tggaaggagct cqaagaaaagtttggatttaaagtcc totacattgacactgateggtotctatgcaactatocca ggaggagaaagtgaggaaataaagaaaaaggctictagaatttgtaaaatacataa attcaaagct coctgg actg citagagcttgaatatgaagggittittatalagaggggattctitcqttacgaagaagagg tatgcagtaatagatgaa gaaggaaaagttcattact.cgtggtttagagatagittaggagagattggagtgaaattgcaaaagaaact caagct agagttittggaga caatactaaaacacggagatgttgaagaagctgtgagaatag taaaagaagtaatacaaaag cittgccaattatcaaatticcaccagagaagctc.gcaatatatgag cagataacaag accattacatgagtataag gcgatagg to ct cacgtagctgttgcaaagaalactagctogctaaaggagttaaaataaag.ccaggaatgg taatt ggatacatag tact tagaggcgatggit CCaattagcaataggg CalattctagotgaggaatacgatCccaaaaag cacaagtatgacgcagaatattacatggagaacCaggttctitcCag Cogg tact taggatattggagggatttgga tacagaaaggaag acct cagataccaaaagacaaga caagttcggcctaact tcc togcttaa.cattaaaaaatcc tag Patent Application Publication Dec. 11, 2003. Sheet 26 of 26 US 2003/0228616 A1 Figure 8 M 0 5 10 15 20 25 % DMSO 9 kb 3 kb 2 kb kb 0.5 kb US 2003/022861.6 A1 Dec. 11, 2003 DNA POLYMERASE MUTANTS WITH REVERSE 0009 Reverse transcription is commonly performed with TRANSCRIPTASE ACTIVITY Viral reverse transcriptases isolated from Avian mycloblas tosis virus (AMV-RT) or Moloney murine leukemia virus RELATED APPLICATIONS (MMLV-RT), which are active in the presence of magnesium OS. 0001. This application is a Continuation-in-Part of U.S. application Ser. No. 10/223,650, filed Aug. 19, 2002,